Clinical Study | Office of Clinical Research

Ship- A Randomized, Placebo-Controlled Pilot Study Of Sulfasalazine For The Treatment Of Primary Sclerosing Cholangitis

Posted Date: May 23, 2019

Investigator: Kenneth Sherman
Specialties:
Type of Study: Drug

We are doing this research study to find out if sulfasalazine can help people with Primary Sclerosing Cholangitis (PSC). Sulfasalazine is approved by the FDA to treat Ulcerative Colitis (UC) and Crohn’s disease (CD), but Sulfasalazine is not approved by the FDA to treat PSC.

Criteria:

To Eligible For This Study Patients Must Have Been Diagnosed With Psc And Inflamatory Bowel Disease (Either Chron's Or Ulcerative Colitis).

Keywords:

Psc, Ibd

For More Information:

Elizabeth Stambrook
513-584-2363
liz.stambrook@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List